Get started
MEDPLUS HEALTH SERVICES LIMITEMEDPLUS HEALTH SERVICES LIMITEMEDPLUS HEALTH SERVICES LIMITE

MEDPLUS HEALTH SERVICES LIMITE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MEDPLUS chart


Full chart

MEDPLUS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪106.01 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
80.20
Basic EPS (TTM)
11.10 INR
Net income (FY)
‪654.73 M‬ INR
Revenue (FY)
‪56.25 B‬ INR
Shares float
‪49.15 M‬
Beta (1Y)
0.57

Employees


Employees (FY)
‪21.72 K‬
Change (1Y)
‪+2.09 K‬ +10.65%
Revenue / Employee (1Y)
‪2.59 M‬ INR
Net income / Employee (1Y)
‪30.15 K‬ INR

About MEDPLUS HEALTH SERV LTD


Sector
Retail Trade
Industry
Drugstore Chains
CEO
Madhukar Reddy Gangadi
Website
medplusindia.com
Headquarters
Hyderabad
Founded
2006
ISIN
INE804L01022
FIGI
BBG013YXGVH8
MedPlus Health Services Ltd. engages in the provision of operation of pharmacies. It operates through the following segments: Retail, Diagnostics, and Others. The Retail segment focuses on the sale of pharmaceuticals and general items. The Diagnostics segment involves the pathology and radiology services. The Others segment includes insurance broking business. Its pharmacies carry medicines, vitamins, medical devices, test kits, and fast-moving consumer goods. It also conducts pathological services and distributes medical and surgical supplies through RiteCure and its online pharmacy Medplus Mart. The company was founded by Madhukar Gangadi in 2006 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MEDPLUS news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as MEDPLUS.

Frequently Asked Questions


The current price of MEDPLUS is 950.90 INR — it has increased by 7.36% in the past 24 hours. Watch MEDPLUS HEALTH SERVICES LIMITE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MEDPLUS HEALTH SERVICES LIMITE stocks are traded under the ticker MEDPLUS.
MEDPLUS stock has risen by 11.90% compared to the previous week, the month change is a 16.12% rise, over the last year MEDPLUS HEALTH SERVICES LIMITE has showed a 34.03% increase.
We've gathered analysts' opinions on MEDPLUS HEALTH SERVICES LIMITE future price: according to them, MEDPLUS price has a max estimate of 1,000.00 INR and a min estimate of 857.00 INR. Watch MEDPLUS chart and read a more detailed MEDPLUS HEALTH SERVICES LIMITE stock forecast: see what analysts think of MEDPLUS HEALTH SERVICES LIMITE and suggest that you do with its stocks.
MEDPLUS reached its all-time high on Jan 20, 2022 with the price of 1,343.00 INR, and its all-time low was 570.00 INR and was reached on Nov 10, 2022. View more price dynamics on MEDPLUS chart.
See other stocks reaching their highest and lowest prices.
MEDPLUS stock is 11.47% volatile and has beta coefficient of 0.57. Track MEDPLUS HEALTH SERVICES LIMITE stock price on the chart and check out the list of the most volatile stocks — is MEDPLUS HEALTH SERVICES LIMITE there?
Today MEDPLUS HEALTH SERVICES LIMITE has the market capitalization of ‪106.01 B‬, it has decreased by −0.11% over the last week.
Yes, you can track MEDPLUS HEALTH SERVICES LIMITE financials in yearly and quarterly reports right on TradingView.
MEDPLUS HEALTH SERVICES LIMITE is going to release the next earnings report on May 27, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDPLUS earnings for the last quarter are 3.80 INR per share, whereas the estimation was 2.70 INR resulting in a 40.74% surprise. The estimated earnings for the next quarter are 3.80 INR per share. See more details about MEDPLUS HEALTH SERVICES LIMITE earnings.
MEDPLUS HEALTH SERVICES LIMITE revenue for the last quarter amounts to ‪15.61 B‬ INR, despite the estimated figure of ‪15.94 B‬ INR. In the next quarter, revenue is expected to reach ‪16.08 B‬ INR.
MEDPLUS net income for the last quarter is ‪458.86 M‬ INR, while the quarter before that showed ‪387.36 M‬ INR of net income which accounts for 18.46% change. Track more MEDPLUS HEALTH SERVICES LIMITE financial stats to get the full picture.
No, MEDPLUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2025, the company has ‪21.72 K‬ employees. See our rating of the largest employees — is MEDPLUS HEALTH SERVICES LIMITE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDPLUS HEALTH SERVICES LIMITE EBITDA is ‪4.57 B‬ INR, and current EBITDA margin is 6.33%. See more stats in MEDPLUS HEALTH SERVICES LIMITE financial statements.
Like other stocks, MEDPLUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDPLUS HEALTH SERVICES LIMITE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDPLUS HEALTH SERVICES LIMITE technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDPLUS HEALTH SERVICES LIMITE stock shows the strong buy signal. See more of MEDPLUS HEALTH SERVICES LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.